Literature DB >> 33414430

Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression.

Natalia P Alza1,2,3, Melisa A Conde1,3,4, Paola G Scodelaro-Bilbao3,4, Gabriela A Salvador5,6,7.   

Abstract

α-synuclein (α-syn) accumulation and aggregation is a common pathological factor found in synucleinopathies, a group of neurodegenerative disorders that includes Parkinson´s disease (PD). It has been proposed that lipid dyshomeostasis is responsible for the occurrence of PD-related processes, however, the precise role of lipids in the onset and progression of neurodegenerative disorders remains unclear. Our aim was to investigate the effect of α-syn overexpression on neutral lipid metabolism and how this impacts on neuronal fate. We found lipid droplet (LD) accumulation in cells overexpressing α-syn to be associated with a rise in triacylglycerol (TAG) and cholesteryl ester (CE) levels. α-syn overexpression promoted diacylglycerol acyltransferase 2 upregulation and acyl-CoA synthetase activation, triggering TAG buildup, that was accompanied by an increase in diacylglycerol acylation. Moreover, the CE increment was associated with higher activity of acyl-CoA:cholesterol acyltransferase. Interestingly, α-syn overexpression increased cholesterol lysosomal accumulation. We observed that sterol regulatory element-binding protein (SREBP)-1 and SREBP-2 were differentially regulated by α-syn overexpression. The latter gave rise to a reduction in SREBP-1 nuclear translocation and consequently in fatty acid synthase expression, whereas it produced an increase in SREBP-2 nuclear localization. Surprisingly, and despite increased cholesterol levels, SREBP-2 downstream genes related to cholesterolgenesis were not upregulated as expected. Notably, phospholipid (PL) levels were diminished in cells overexpressing α-syn. This decrease was related to the activation of phospholipase A2 (PLA2) with a concomitant imbalance of the PL deacylation-acylation cycle. Fatty acids released from PLs by iPLA2 and cPLA2 action were esterified into TAGs, thus promoting a biological response to α-syn overexpression with uncompromised cell viability. When the described steady-state was disturbed under conditions favoring higher levels of α-syn, the response was an enhanced LD accumulation, this imbalance ultimately leading to neuronal death.

Entities:  

Year:  2021        PMID: 33414430      PMCID: PMC7791139          DOI: 10.1038/s41419-020-03254-7

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  67 in total

1.  Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes.

Authors:  Goichi Beck; Yuki Sugiura; Koei Shinzawa; Shinsuke Kato; Mitsutoshi Setou; Yoshihide Tsujimoto; Saburo Sakoda; Hisae Sumi-Akamaru
Journal:  J Neurosci       Date:  2011-08-03       Impact factor: 6.167

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

4.  In vitro 6-hydroxydopamine-induced neurotoxicity: New insights on NFκB modulation.

Authors:  Pablo A Iglesias González; Melisa A Conde; Verónica González-Pardo; Romina M Uranga; Gabriela A Salvador
Journal:  Toxicol In Vitro       Date:  2019-06-25       Impact factor: 3.500

5.  Structural and morphological characterization of aggregated species of α-synuclein induced by docosahexaenoic acid.

Authors:  Giorgia De Franceschi; Erica Frare; Micaela Pivato; Annalisa Relini; Amanda Penco; Elisa Greggio; Luigi Bubacco; Angelo Fontana; Patrizia Polverino de Laureto
Journal:  J Biol Chem       Date:  2011-04-28       Impact factor: 5.157

Review 6.  Interplay between α-synuclein amyloid formation and membrane structure.

Authors:  Emma I O'Leary; Jennifer C Lee
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-02       Impact factor: 3.036

7.  Yeast cells provide insight into alpha-synuclein biology and pathobiology.

Authors:  Tiago Fleming Outeiro; Susan Lindquist
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

8.  The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.

Authors:  Anne-Laure Mahul-Mellier; Johannes Burtscher; Niran Maharjan; Laura Weerens; Marie Croisier; Fabien Kuttler; Marion Leleu; Graham W Knott; Hilal A Lashuel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

Review 9.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 10.  Lipid Droplets and the Management of Cellular Stress.

Authors:  Eva Jarc; Toni Petan
Journal:  Yale J Biol Med       Date:  2019-09-20
View more
  4 in total

1.  Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites.

Authors:  Stephanie Vrijsen; Céline Vrancx; Mara Del Vecchio; Johannes V Swinnen; Patrizia Agostinis; Joris Winderickx; Peter Vangheluwe; Wim Annaert
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

2.  Phosphatidylethanolamine Deficiency and Triglyceride Overload in Perilesional Cortex Contribute to Non-Goal-Directed Hyperactivity after Traumatic Brain Injury in Mice.

Authors:  Lisa Hahnefeld; Alexandra Vogel; Robert Gurke; Gerd Geisslinger; Michael K E Schäfer; Irmgard Tegeder
Journal:  Biomedicines       Date:  2022-04-15

Review 3.  Neurons and Glia Interplay in α-Synucleinopathies.

Authors:  Panagiota Mavroeidi; Maria Xilouri
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

4.  Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.

Authors:  Kelly E Glajch; Tim E Moors; Yi Chen; Pascal A Bechade; Alice Y Nam; Molly M Rajsombath; Thomas D McCaffery; Ulf Dettmer; Andreas Weihofen; Warren D Hirst; Dennis J Selkoe; Silke Nuber
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.